How to manage patients on rivaroxaban in the emergency department: a statement of the Italian society of emergency medicine advisory board.

摘要: Rivaroxaban, a new oral anticoagulant, has been approved in many countries and its everyday use clinical practice is increasing. Thus, the chances for an emergency physician to encounter rivaroxaban-treated patients situations have increased. Here, authors address main issues terms of prescription rivaroxaban management these cases minor or major bleeding, urgent surgery, atrial fibrillation requiring cardioversion, acute ischemic stroke, ST-elevation myocardial infarction, onset recent infarction. The recommendations reached are based on literature review panel discussion advisory board SIMEU, Italian Society Emergency Medicine.